Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 01/01/2008
Publisher: CLSI
File Format: PDF
$90.00$180.00
Published:01/01/2008
Pages:64
File Size:1 file , 1.5 MB
Note:This product is unavailable in Russia, Belarus
This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline, M44-A
$135.00 $270.18
Clinical Laboratory Safety; Approved Guideline, GP17-A2
$118.00 $236.69
Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard, M22A3E
$90.00 $180.00
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Informational Supplement, M31-S1
